Pilot study of novel lab methodology and testing of platelet function in adolescent women with heavy menstrual bleeding

Anne D. Rocheleau, Ayesha Khader, Anh T.P. Ngo, Colin Boehnlein, Cara McDavitt, Susan Lattimore, Michael Recht, Owen McCarty, Kristina Haley

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BackgroundApproximately 40% of adolescent women experience heavy menstrual bleeding (HMB), and 10-62% of them have an underlying bleeding disorder (BD). Diagnosing a BD remains challenging because of limitations of available clinical platelet function assays. The aim of this study was to characterize platelet function in a population of adolescent women with HMB using small-volume whole-blood assays.MethodsAnticoagulated whole blood was used to assess platelet GPIIbIIIa activation, α-granule secretion, and aggregation in response to multiple agonists. Platelet adhesion on collagen or von Willebrand Factor (VWF) under static and shear flow was also assessed.ResultsFifteen participants with HMB were included in the study, of which eight were diagnosed with a clinically identifiable BD. Platelet activation was blunted in response to calcium ionophore in participants without a BD diagnosis compared with that in all other participants. Impaired GPIIbIIIa activation was observed in response to all GPCR agonists, except adenosine diphosphate (ADP), in participants with qualitative platelet disorders. Our assays detected platelet aggregation in the majority of participants with a BD in response to ADP, collagen-related peptide (CRP), thrombin receptor activator 6 (TRAP-6), or U46619. Platelet adhesion and aggregation on collagen and VWF was decreased for participants with VWD.ConclusionParticipants with and without BD exhibited aberrant platelet function in several assays in response to select agonists.

Original languageEnglish (US)
Pages (from-to)693-701
Number of pages9
JournalPediatric Research
Volume83
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Blood Platelets
Hemorrhage
Platelet Activation
von Willebrand Factor
Platelet Aggregation
Adenosine Diphosphate
Collagen
Thrombin Receptors
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Peptide Receptors
Calcium Ionophores
Blood Volume
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pilot study of novel lab methodology and testing of platelet function in adolescent women with heavy menstrual bleeding. / Rocheleau, Anne D.; Khader, Ayesha; Ngo, Anh T.P.; Boehnlein, Colin; McDavitt, Cara; Lattimore, Susan; Recht, Michael; McCarty, Owen; Haley, Kristina.

In: Pediatric Research, Vol. 83, No. 3, 01.03.2018, p. 693-701.

Research output: Contribution to journalArticle

Rocheleau, Anne D. ; Khader, Ayesha ; Ngo, Anh T.P. ; Boehnlein, Colin ; McDavitt, Cara ; Lattimore, Susan ; Recht, Michael ; McCarty, Owen ; Haley, Kristina. / Pilot study of novel lab methodology and testing of platelet function in adolescent women with heavy menstrual bleeding. In: Pediatric Research. 2018 ; Vol. 83, No. 3. pp. 693-701.
@article{e2390bebc08f4d9bbf3d774d5544be08,
title = "Pilot study of novel lab methodology and testing of platelet function in adolescent women with heavy menstrual bleeding",
abstract = "BackgroundApproximately 40{\%} of adolescent women experience heavy menstrual bleeding (HMB), and 10-62{\%} of them have an underlying bleeding disorder (BD). Diagnosing a BD remains challenging because of limitations of available clinical platelet function assays. The aim of this study was to characterize platelet function in a population of adolescent women with HMB using small-volume whole-blood assays.MethodsAnticoagulated whole blood was used to assess platelet GPIIbIIIa activation, α-granule secretion, and aggregation in response to multiple agonists. Platelet adhesion on collagen or von Willebrand Factor (VWF) under static and shear flow was also assessed.ResultsFifteen participants with HMB were included in the study, of which eight were diagnosed with a clinically identifiable BD. Platelet activation was blunted in response to calcium ionophore in participants without a BD diagnosis compared with that in all other participants. Impaired GPIIbIIIa activation was observed in response to all GPCR agonists, except adenosine diphosphate (ADP), in participants with qualitative platelet disorders. Our assays detected platelet aggregation in the majority of participants with a BD in response to ADP, collagen-related peptide (CRP), thrombin receptor activator 6 (TRAP-6), or U46619. Platelet adhesion and aggregation on collagen and VWF was decreased for participants with VWD.ConclusionParticipants with and without BD exhibited aberrant platelet function in several assays in response to select agonists.",
author = "Rocheleau, {Anne D.} and Ayesha Khader and Ngo, {Anh T.P.} and Colin Boehnlein and Cara McDavitt and Susan Lattimore and Michael Recht and Owen McCarty and Kristina Haley",
year = "2018",
month = "3",
day = "1",
doi = "10.1038/pr.2017.298",
language = "English (US)",
volume = "83",
pages = "693--701",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Pilot study of novel lab methodology and testing of platelet function in adolescent women with heavy menstrual bleeding

AU - Rocheleau, Anne D.

AU - Khader, Ayesha

AU - Ngo, Anh T.P.

AU - Boehnlein, Colin

AU - McDavitt, Cara

AU - Lattimore, Susan

AU - Recht, Michael

AU - McCarty, Owen

AU - Haley, Kristina

PY - 2018/3/1

Y1 - 2018/3/1

N2 - BackgroundApproximately 40% of adolescent women experience heavy menstrual bleeding (HMB), and 10-62% of them have an underlying bleeding disorder (BD). Diagnosing a BD remains challenging because of limitations of available clinical platelet function assays. The aim of this study was to characterize platelet function in a population of adolescent women with HMB using small-volume whole-blood assays.MethodsAnticoagulated whole blood was used to assess platelet GPIIbIIIa activation, α-granule secretion, and aggregation in response to multiple agonists. Platelet adhesion on collagen or von Willebrand Factor (VWF) under static and shear flow was also assessed.ResultsFifteen participants with HMB were included in the study, of which eight were diagnosed with a clinically identifiable BD. Platelet activation was blunted in response to calcium ionophore in participants without a BD diagnosis compared with that in all other participants. Impaired GPIIbIIIa activation was observed in response to all GPCR agonists, except adenosine diphosphate (ADP), in participants with qualitative platelet disorders. Our assays detected platelet aggregation in the majority of participants with a BD in response to ADP, collagen-related peptide (CRP), thrombin receptor activator 6 (TRAP-6), or U46619. Platelet adhesion and aggregation on collagen and VWF was decreased for participants with VWD.ConclusionParticipants with and without BD exhibited aberrant platelet function in several assays in response to select agonists.

AB - BackgroundApproximately 40% of adolescent women experience heavy menstrual bleeding (HMB), and 10-62% of them have an underlying bleeding disorder (BD). Diagnosing a BD remains challenging because of limitations of available clinical platelet function assays. The aim of this study was to characterize platelet function in a population of adolescent women with HMB using small-volume whole-blood assays.MethodsAnticoagulated whole blood was used to assess platelet GPIIbIIIa activation, α-granule secretion, and aggregation in response to multiple agonists. Platelet adhesion on collagen or von Willebrand Factor (VWF) under static and shear flow was also assessed.ResultsFifteen participants with HMB were included in the study, of which eight were diagnosed with a clinically identifiable BD. Platelet activation was blunted in response to calcium ionophore in participants without a BD diagnosis compared with that in all other participants. Impaired GPIIbIIIa activation was observed in response to all GPCR agonists, except adenosine diphosphate (ADP), in participants with qualitative platelet disorders. Our assays detected platelet aggregation in the majority of participants with a BD in response to ADP, collagen-related peptide (CRP), thrombin receptor activator 6 (TRAP-6), or U46619. Platelet adhesion and aggregation on collagen and VWF was decreased for participants with VWD.ConclusionParticipants with and without BD exhibited aberrant platelet function in several assays in response to select agonists.

UR - http://www.scopus.com/inward/record.url?scp=85045568420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045568420&partnerID=8YFLogxK

U2 - 10.1038/pr.2017.298

DO - 10.1038/pr.2017.298

M3 - Article

C2 - 29166373

AN - SCOPUS:85045568420

VL - 83

SP - 693

EP - 701

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 3

ER -